Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical imiquimod skin inflammation challenge study in healthy volunteers
NL-OMON43402Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Apr 2016
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of imiquimod in dermatitis (3 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Pharmacodynamic effects of topically applied imiquimod and Dose-response relationship. Started Apr 2016; status: active, not recruiting.
02
Drugs
imiquimod
03
Conditions
dermatitis
Beyond the preview
Go deeper on NL-OMON43402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43402.